Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gene therapy shot aims to boost vital proteins in healthy seniors

NCT ID NCT07285629

First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 23 times

Summary

This early-stage study tests whether a gene therapy injection can safely raise levels of two key proteins—klotho and follistatin—in healthy adults aged 50 to 80. Researchers will measure protein levels in the blood and track any side effects, as well as changes in quality of life. The goal is to gather initial safety data and explore potential cognitive and health benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Apeiron Center

    RECRUITING

    Austin, Texas, 78701, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Global Alliance of Regenerative Medicine (GARM) Clinic

    NOT_YET_RECRUITING

    Roatán, Bay Islands, Honduras

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.